Skip to content

Oncologic Timely Palliative Care And Remote Monitoring With Electronic Assessments And Telehealth (ON-TARGET)

Oncologic Timely Palliative Care And Remote Monitoring With Electronic Assessments And Telehealth (ON-TARGET)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07674797
Enrollment
300
Registered
2026-06-30
Start date
2026-11-22
Completion date
2034-06-30
Last updated
2026-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electronic Assessments, Oncologic, Palliative Care, Remote Monitoring, Telehealth

Brief summary

To examine how we can provide supportive care for patients with advanced cancer better tailored to their needs

Detailed description

Primary Objectives Objective 1: To compare the impact of timely SPC referral and enhanced usual care (i.e., selective referral) on the proportion of participants with an outpatient SPC consultation at (a) 12 weeks (primary outcome) and (b) 24 weeks post-initial screening.

Interventions

OTHERQuestionnaire and Physical Exam

Patient will complete questionnaires and physical exams

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligibility Criteria * Age ≥ 18 * Outpatients who are within 12 weeks of diagnosis of metastatic solid tumors and seen by one of the participating medical oncologists * Eastern Cooperative Oncology Group Performance Status 0.2 * Able to speak English or Spanish

Exclusion criteria

. Cognitive impairment in the opinion of the oncologist necessitating need for a surrogate decision making. • Previously seen by SPC team at UT MD Anderson

Design outcomes

Primary

MeasureTime frame
Self Report QuestionnaireThrough study completion; an average of 1 year

Countries

United States

Contacts

CONTACTDavid Hui, MD
dhui@mdanderson.org713-792-6258
PRINCIPAL_INVESTIGATORDavid Hui, MD

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 1, 2026